Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
D000081:Acetamides; D000230:Adenocarcinoma / Q000139:chemically induced / Q000473:pathology; D002293:Adenocarcinoma, Scirrhous / Q000139:chemically induced; D000232:Adenofibroma / Q000139:chemically induced; D000818:Animals; D002273:Carcinogens; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced / Q000473:pathology; D004285:Dogs; D005260:Female; D005559:Formamides; D005704:Gallbladder / Q000187:drug effects; D005706:Gallbladder Neoplasms / Q000139:chemically induced* / Q000473:pathology; D007680:Kidney Neoplasms / Q000139:chemically induced; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009581:Nitrofurans; D013844:Thiazoles; D014516:Ureteral Neoplasms / Q000139:chemically induced; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000473:pathology; D014565:Urogenital Neoplasms / Q000139:chemically induced*; D014566:Urogenital System / Q000187:drug effects
D000081:Acetamides; D002273:Carcinogens; D005559:Formamides; D009581:Nitrofurans; D013844:Thiazoles